{
      "brief_title": [
            "therapy",
            "uveitis"
      ],
      "brief_summary": [
            "uveitis",
            "refer",
            "intraocular",
            "inflammatory",
            "disease",
            "important",
            "cause",
            "visual",
            "loss",
            "standard",
            "systemic",
            "immunosuppressive",
            "medication",
            "uveitis",
            "cause",
            "significant",
            "adverse",
            "effect",
            "consequently",
            "effective",
            "treatment",
            "safer",
            "side",
            "effect",
            "profile",
            "highly",
            "desirable",
            "pilot",
            "study",
            "permit",
            "enrollment",
            "12",
            "adult",
            "intermediate",
            "posterior",
            "uveitis",
            "require",
            "treatment",
            "maintain",
            "visual",
            "function",
            "extend",
            "protocol",
            "begin",
            "evaluation",
            "safety",
            "potential",
            "efficacy",
            "intravenous",
            "iv",
            "daclizumab",
            "treatment",
            "uveitis",
            "reduce",
            "eliminate",
            "standard",
            "medication",
            "commensurate",
            "standard",
            "care",
            "subcutaneous",
            "sc",
            "daclizumab",
            "treatment",
            "become",
            "available",
            "eligible",
            "participant",
            "offer",
            "continue",
            "daclizumab",
            "treatment",
            "use",
            "new",
            "sc",
            "formulation",
            "though",
            "may",
            "elect",
            "remain",
            "iv",
            "treatment",
            "therapeutic",
            "benefit",
            "sustain",
            "use",
            "sc",
            "formulation",
            "maintenance",
            "therapy",
            "continue",
            "clinically",
            "indicate",
            "participant",
            "repeatedly",
            "fail",
            "sc",
            "therapy",
            "permit",
            "revert",
            "iv",
            "daclizumab",
            "regimen",
            "previously",
            "use",
            "may",
            "exit",
            "study",
            "treatment",
            "failure",
            "sc",
            "treatment",
            "begin",
            "short",
            "sc",
            "induction",
            "2",
            "follow",
            "1",
            "treatment",
            "schedule",
            "protocol",
            "originally",
            "specify",
            "participant",
            "monitor",
            "routinely",
            "dose",
            "receive",
            "additionally",
            "participate",
            "pharmacokinetic",
            "study",
            "monitor",
            "sc",
            "formulation",
            "bioavailability",
            "daclizumab",
            "humanize",
            "monoclonal",
            "antibody",
            "hat",
            "zenapax",
            "interfere",
            "inflammatory",
            "process",
            "involvement",
            "interleukin",
            "2",
            "receptor",
            "first",
            "5",
            "year",
            "study",
            "iv",
            "product",
            "available",
            "sc",
            "formulation",
            "available",
            "contain",
            "daclizumab",
            "drug",
            "product",
            "preliminary",
            "study",
            "indicate",
            "sc",
            "formulation",
            "well",
            "tolerate",
            "normal",
            "control",
            "subject",
            "autoimmune",
            "disease",
            "patient",
            "repeat",
            "dose",
            "2",
            "primary",
            "objective",
            "examine",
            "safety",
            "potential",
            "efficacy",
            "iv",
            "later",
            "sc",
            "daclizumab",
            "continue",
            "reduce",
            "immunosuppressive",
            "medication",
            "commensurate",
            "standard",
            "care",
            "primary",
            "safety",
            "outcome",
            "discontinuation",
            "study",
            "therapy",
            "due",
            "reduce",
            "vision",
            "occurrence",
            "adverse",
            "event",
            "secondary",
            "outcome",
            "measure",
            "include",
            "visual",
            "acuity",
            "grade",
            "immunosuppressive",
            "medication",
            "anterior",
            "chamber",
            "vitreous",
            "cell",
            "vitreous",
            "haze"
      ],
      "detailed_description": [
            "uveitis",
            "refer",
            "intraocular",
            "inflammatory",
            "disease",
            "important",
            "cause",
            "visual",
            "loss",
            "standard",
            "systemic",
            "immunosuppressive",
            "medication",
            "uveitis",
            "cause",
            "significant",
            "adverse",
            "effect",
            "consequently",
            "effective",
            "treatment",
            "safer",
            "side",
            "effect",
            "profile",
            "highly",
            "desirable",
            "pilot",
            "study",
            "permit",
            "enrollment",
            "12",
            "adult",
            "intermediate",
            "posterior",
            "uveitis",
            "require",
            "treatment",
            "maintain",
            "visual",
            "function",
            "extend",
            "protocol",
            "begin",
            "evaluation",
            "safety",
            "potential",
            "efficacy",
            "intravenous",
            "iv",
            "daclizumab",
            "treatment",
            "uveitis",
            "reduce",
            "eliminate",
            "standard",
            "medication",
            "commensurate",
            "standard",
            "care",
            "subcutaneous",
            "sc",
            "daclizumab",
            "treatment",
            "become",
            "available",
            "eligible",
            "participant",
            "offer",
            "continue",
            "daclizumab",
            "treatment",
            "use",
            "new",
            "sc",
            "formulation",
            "though",
            "may",
            "elect",
            "remain",
            "iv",
            "treatment",
            "therapeutic",
            "benefit",
            "sustain",
            "use",
            "sc",
            "formulation",
            "maintenance",
            "therapy",
            "continue",
            "clinically",
            "indicate",
            "participant",
            "repeatedly",
            "fail",
            "sc",
            "therapy",
            "permit",
            "revert",
            "iv",
            "daclizumab",
            "regimen",
            "previously",
            "use",
            "may",
            "exit",
            "study",
            "treatment",
            "failure",
            "sc",
            "treatment",
            "begin",
            "short",
            "sc",
            "induction",
            "2",
            "follow",
            "1",
            "treatment",
            "schedule",
            "protocol",
            "originally",
            "specify",
            "participant",
            "monitor",
            "routinely",
            "dose",
            "receive",
            "additionally",
            "participate",
            "pharmacokinetic",
            "study",
            "monitor",
            "sc",
            "formulation",
            "bioavailability",
            "daclizumab",
            "humanize",
            "monoclonal",
            "antibody",
            "hat",
            "zenapax",
            "interfere",
            "inflammatory",
            "process",
            "involvement",
            "interleukin",
            "2",
            "receptor",
            "first",
            "5",
            "year",
            "study",
            "iv",
            "product",
            "available",
            "sc",
            "formulation",
            "available",
            "contain",
            "daclizumab",
            "drug",
            "product",
            "preliminary",
            "study",
            "indicate",
            "sc",
            "formulation",
            "well",
            "tolerate",
            "normal",
            "control",
            "subject",
            "autoimmune",
            "disease",
            "patient",
            "repeat",
            "dose",
            "2",
            "primary",
            "objective",
            "examine",
            "safety",
            "potential",
            "efficacy",
            "iv",
            "later",
            "sc",
            "daclizumab",
            "continue",
            "reduce",
            "immunosuppressive",
            "medication",
            "commensurate",
            "standard",
            "care",
            "primary",
            "safety",
            "outcome",
            "discontinuation",
            "study",
            "therapy",
            "due",
            "reduce",
            "vision",
            "occurrence",
            "adverse",
            "event",
            "secondary",
            "outcome",
            "measure",
            "include",
            "visual",
            "acuity",
            "grade",
            "immunosuppressive",
            "medication",
            "anterior",
            "chamber",
            "vitreous",
            "cell",
            "vitreous",
            "haze"
      ],
      "condition": [],
      "intervention_type": [
            "Drug"
      ],
      "intervention_name": [
            "Daclizumab (Zenapax)"
      ],
      "criteria": [
            "inclusion",
            "criterion",
            "participant",
            "18",
            "year",
            "age",
            "older",
            "participant",
            "diagnosis",
            "intermediate",
            "posterior",
            "uveitis",
            "least",
            "three",
            "month",
            "duration",
            "prior",
            "orginal",
            "enrollment",
            "require",
            "treatment",
            "control",
            "intraocular",
            "inflammatory",
            "disease",
            "least",
            "20",
            "prednisone",
            "equivalent",
            "combination",
            "two",
            "treatment",
            "uveitis",
            "include",
            "example",
            "prednisone",
            "cyclophosphamide",
            "cyclosporine",
            "azathioprine",
            "mycophenolate",
            "mofetil",
            "methotrexate",
            "etc",
            "participant",
            "exhibit",
            "intolerance",
            "indicate",
            "systemic",
            "medication",
            "require",
            "uveitis",
            "though",
            "uveitis",
            "may",
            "control",
            "wish",
            "take",
            "present",
            "medication",
            "due",
            "potential",
            "actual",
            "unacceptable",
            "side",
            "effect",
            "participant",
            "visual",
            "acuity",
            "least",
            "one",
            "eye",
            "better",
            "etdrs",
            "logmar",
            "le",
            "participant",
            "normal",
            "renal",
            "liver",
            "function",
            "evidence",
            "worse",
            "mild",
            "abnormality",
            "define",
            "criterion",
            "participant",
            "currently",
            "pregnant",
            "lactate",
            "participant",
            "reproductive",
            "potential",
            "sexually",
            "active",
            "agree",
            "use",
            "acceptable",
            "birth",
            "control",
            "method",
            "throughout",
            "course",
            "study",
            "exclusion",
            "criterion",
            "participant",
            "age",
            "18",
            "year",
            "participant",
            "receive",
            "previous",
            "treatment",
            "direct",
            "monoclonal",
            "antibody",
            "investigational",
            "agent",
            "would",
            "interfere",
            "ability",
            "evaluate",
            "safety",
            "efficacy",
            "pharmacokinetics",
            "daclizumab",
            "participant",
            "history",
            "diagnosis",
            "behcet",
            "disease",
            "participant",
            "significant",
            "active",
            "infection",
            "participant",
            "history",
            "cancer",
            "skin",
            "cancer",
            "diagnose",
            "within",
            "past",
            "5",
            "year",
            "participant",
            "hypersensitive",
            "fluorescein",
            "dye"
      ],
      "gender": "All",
      "minimum_age": [
            "18",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": "No",
      "keyword": [
            "interleukin",
            "2"
      ],
      "mesh_term": [],
      "id": "NCT00001526"
}